ASH 2017 in Atlanta, USA: CML patient advocates information

ashlogoJust two weeks left until the 59th ASH Annual Meeting and Exposition opens its doors on 9th December in Atlanta, USA. We are hoping to see many CML Advocates at #ASH17!

This is the world’s most comprehensive haematology event of the year and it is very important to be ready before the meeting as CML advocates in order not to miss out on any important session about chronic myeloid leukaemia.

We are happy to share with you some key information about CML sessions hoping it will assist you to prepare and outline your days and make the most out of your time whilst at #ASH17.

Click on "Read more" and check what is offered for patient advocates, haematologists and other stakeholders interested in CML at American Society of Hematology Annual Meeting this year. If you are coming to #ASH17, don't miss any of them, they will all be really interesting!

Read more ...


The Glivec patent expires in most countries latest on 21 Dec 2016.

The CML Advocates Network has been following the situation of TKI generics closely for 3 years, and has now provided a webinar which summarizes the current status.

This webinar answers some important questions, such as:

  • What are generics, and do they differentiate from innovator products?
  • Which generics of CML Tyrosine Kinase Inhibitors exist?
  • What do we know about efficacy and safety?
  • What information on CML generics is available to patients?
  • What has the patient advocacy community done so far?
  • What can patients and patient advocacy groups do about CML generics?

More can be found on our CML Advocates Network Knowledge Base on CML Generics at

If you want access to the slides, please contact Jan Geissler at .

Webstream via AuthorStream (allows to skip slides)











Please donate!

Please donate!


Tweet Feed

@WECANadvocate Thank you so much, @WECANadvocate! The aim is to provide #CML patients and HCPs with more evidence w……

Monday, 19 March 2018 in reply to WECANadvocate

One of our members, @cmlnet is running a survey to find out what the patient experience is on……

Retweeted Monday, 19 March 2018

Have you taken the #TFR4CML survey yet? If not, the weekend is a good moment to dedicate 20 minutes to this questio……

Saturday, 17 March 2018